Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-922-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity LD50 (cut-off value): 5000 mg/kg bw (rat, OECD TG 423)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 17 December 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Animals
- Sprague Dawley
- Source: in-house bred animals
- Body Weight Range at Receipt: 160.37 g to 176.61 g
- Age at Treatment:10 to 11 weeks
Housing and Feeding Conditions
- Full barrier in an air-conditioned room
- Temperature: 19.1-22.9 °C
- Relative humidity: 41-69%
- Artificial light, sequence being 12 hours light, 12 hours dark
- Air change: 12-15 x / hour
- Free access to Altromin maintenance diet for rats and mice
- Free access to tap water
- The animals were kept in groups in standard polypropylene c
- Adequate acclimatisation period (at least five days) under laboratory conditions - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- see detaails on study design
- Doses:
- Prior to the administration a detailed clinical observation was made of all animals. Healthy young adult animals used for Step-I, Step-I confirmation, Step-II and Step-II confirmation were acclimatized for five, seven, eight and twelve days respectively to laboratory condition prior to treatment and were observed for clinical signs once daily.Prior to the administration food was withheld from the test animals for 16 to 19 hours (access to water was permitted). Following the period of fasting the animals were weighed and the test item was administered. Food was provided again approximately 4 hours post dosing.
The test item was administered by oral gavage as a single dose of 300 mg/kg body weight (a dose volume of 10 mL/kg body weight) to three female rats in Step I. No clinical signs of toxicity and mortality observed at 300 mg/kg body weight in Step I. Hence, as per the decision rules governing the sequential procedure presented in the OECD 423 test guideline Annex 2c, Step I confirmation was conducted using three more female rats approximately after 24 hours of observation by administering a single dose of 300 mg/kg body weight of the test item. No clinical signs of toxicity and mortality observed at 300 mg/kg body weight in Step I confirmation. Hence, as per the decision rules governing the sequential procedure presented in the OECD 423 test guideline Annex 2c, Step-II was conducted using three more female rats approximately after 24 hours of observation by administering a single dose of 2000 mg/kg body weight. No clinical signs of toxicity and mortality were observed. Hence, as per the decision rules governing the sequential procedure presented in the OECD 423 test guideline Annex 2c, Step-II confirmation was conducted using additional three female rats approximately after 48 hours of observation. - No. of animals per sex per dose:
- 3 female animals per step per dose- 2 doses performed
- Control animals:
- no
- Details on study design:
- The animals were dosed in a stepwise procedure with three female animals per step. The LD50 of the test item was not available, a starting dose of 300 mg/kg body weight (10 ml/kg BW) was selected from the fixed dose levels of 5, 50, 300 and 2000 mg/kg body weight. The test item was administered by oral gavage as a single dose of 300 mg/kg body weight to three female rats in Step I. No clinical signs of toxicity and mortality observed at 300 mg/kg body weight in Step I. Hence, as per the decision rules governing the sequential procedure presented in the OECD 423 test guideline Annex 2c, Step I confirmation was conducted using three more female rats approximately after 24 hours of observation by administering a single dose of 300 mg/kg body weight of the test item. No clinical signs of toxicity and mortality observed at 300 mg/kg body weight in Step I confirmation. Hence, as per the decision rules governing the sequential procedure presented in the OECD 423 test guideline Annex 2c, Step-II was conducted using three more female rats approximately after 24 hours of observation by administering a single dose of 2000 mg/kg body weight. No clinical signs of toxicity and mortality were observed. Hence, as per the decision rules governing the sequential procedure presented in the OECD 423 test guideline Annex 2c, Step-II confirmation was conducted using additional three female rats approximately after 48 hours of observation. No clinical signs of toxicity and mortality observed.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- 5 000 mg/kg bw
- Mortality:
- All animals survived until the end of the study without showing signs of toxicity.
- Clinical signs:
- other: All animals survived until the end of the study without showing signs of toxicity.
- Gross pathology:
- At necropsy, no macroscopic findings were observed in any animal of any step.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the results of the experiment, it is concluded that the LD50cut off value for the test item is 5000 mg/kg body weight when administered as a single dose by oral gavage to female Sprague Dawley rat as per OECD Guidelines for Testing of Chemicals (No. 423, Section 4: Health Effects) on conduct of “Acute Oral Toxicity - Acute Toxic Class Method”. “No Classification” (i.e. no acute toxicity hazard category) has to be applied according to Classification, labelling and packaging (CLP) of substances and mixtures as per Regulation (EC) No 1272/2008.
- Executive summary:
The test item was evaluated for acute oral toxicity in Sprague Dawley rats as per OECD Guideline No. 423: Acute Oral Toxicity - Acute Toxic Class Method adopted on 17 December 2001. A total of 12 females (3 females for each Step-I, Step-I confirmation, Step-II and Step-II confirmation) were used for the experiment. All the animals of Step-I, Step-I confirmation were dosed with 300 mg/kg. Step-II and Step-II confirmation were dosed at 2000 mg/kg body weight of the test item through oral route respectively. No clinical signs of toxicity and mortality was observed at Step-I, Step-I confirmation, Step-II and Step-II confirmation. Based on the results of the experiment, it is concluded that the LD50cut off value for the test item ITD is 5000 mg/kg body weight. “No Classification” (i.e. no acute toxicity hazard category) has to be applied according to Classification, labelling and packaging (CLP) of substances and mixtures as per Regulation (EC) No 1272/2008.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- High quality, GLP study according to OECD TG Guideline
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The submission substance was evaluated for acute oral toxicity in Sprague Dawley rats as per OECD Guideline No. 423. A total of 12 females (3 females for each Step-I, Step-I confirmation, Step-II and Step-II confirmation) were used for the experiment. All the animals of Step-I, Step-I confirmation were dosed with 300 mg/kg. Step-II and Step-II confirmation were dosed at 2000 mg/kg body weight of the test item through oral route respectively.No clinical signs of toxicity and mortality was observed at Step-I, Step-I confirmation, Step-II and Step-II confirmation.Based on the results of the experiment, it is concluded that the LD50cut off value for the test item ITD is 5000 mg/kg body weight.“No Classification” (i.e. no acute toxicity hazard category) has to be applied according to Classification, labelling and packaging (CLP) of substances and mixtures as per Regulation (EC) No 1272/2008.
Justification for classification or non-classification
Based on the results from available guideline studies which revealed a LD50 cut-off value of 5000 mg/kg body weight, the registration substance is not subject to labelling and classification requirements with regard to oral exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.